[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and India Glucagon Like Peptide-1 (GLP-1) Agonists Market Research by Company, Type & Application 2013-2025

August 2018 | 105 pages | ID: GB2B6C21B89EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

Market Segment as follows:

By Type
  • Exenatied
  • Liraglutide
  • Lixisenatide
  • Albiglutide
  • Dulaglutide
By Application
  • Hospital
  • Pharmacy
  • Others
By Company
  • Novo Nordisk
  • AstraZeneca
  • Eli Lily
  • GSK
  • Sanofi
  • Bristol-Myers Squibb
  • Amylin
The main contents of the report including:

Section 1:
Product definition, type and application, global and India market overview;
Section 2:
Global and India Market competition by company;
Section 3:
Global and India sales revenue, volume and price by type;
Section 4:
Global and India sales revenue, volume and price by application;
Section 5:
India export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Exenatied
    1.1.2.2 Liraglutide
    1.1.2.3 Lixisenatide
    1.1.2.4 Albiglutide
    1.1.2.5 Dulaglutide
  1.1.3 Market by Application
    1.1.3.1 Hospital
    1.1.3.2 Pharmacy
    1.1.3.3 Others
1.2 Global and Regional Market Size
  1.2.1 Global Overview
  1.2.2 India Overview

2 GLOBAL AND REGIONAL MARKET BY COMPANY

2.1 Global
  2.1.1 Global Sales by Company
  2.1.2 Global Price by Company
2.2 India
  2.2.1 India Sales by Company
  2.2.2 India Price by Company

3 GLOBAL AND REGIONAL MARKET BY TYPE

3.1 Global
  3.1.1 Global Sales by Type
  3.1.2 Global Price by Type
3.2 India
  3.2.1 India Sales by Type
  3.2.2 India Price by Type

4 GLOBAL AND REGIONAL MARKET BY APPLICATION

4.1 Global
  4.1.1 Global Sales by Application
  4.1.2 Global Price by Application
4.2 India
  4.2.1 India Sales by Application
  4.2.2 India Price by Application

5 REGIONAL TRADE

5.1 Export
5.2 Import

6 KEY MANUFACTURERS

6.1 Novo Nordisk
  6.1.2 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 AstraZeneca
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Eli Lily
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 GSK
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Sanofi
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Bristol-Myers Squibb
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Amylin
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Raw Materials

8 MARKET ENVIRONMENT

8.1 SWOT
8.2 Porter's Five Forces

9 CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table India Market Sales Revenue by Company 2013-2017
Table India Market Sales Revenue Share by Company 2013-2017
Table India Market Sales Volume by Company 2013-2017
Table India Market Sales Volume Share by Company 2013-2017
Table India Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table India Market Sales Revenue by Type 2013-2017
Table India Market Sales Revenue Share by Type 2013-2017
Table India Market Sales Volume by Type 2013-2017
Table India Market Sales Volume Share by Type 2013-2017
Table India Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table India Market Sales Revenue by Application 2013-2017
Table India Market Sales Revenue Share by Application 2013-2017
Table India Market Sales Volume by Application 2013-2017
Table India Market Sales Volume Share by Application 2013-2017
Table India Price by Application 2013-2017
Table India Export 2013-2017 (Million USD)
Table India Export 2013-2017 (Volume)
Table India Import 2013-2017 (Million USD)
Table India Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lily
Table Sales Revenue, Volume, Price, Cost and Margin of GSK
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of Amylin

LIST OF FIGURES

Figure Exenatied Market Size and CAGR 2013-2017 (Million USD)
Figure Exenatied Market Size and CAGR 2013-2017 (Volume)
Figure Exenatied Market Forecast and CAGR 2018-2025 (Million USD)
Figure Exenatied Market Forecast and CAGR 2018-2025 (Volume)
Figure Liraglutide Market Size and CAGR 2013-2017 (Million USD)
Figure Liraglutide Market Size and CAGR 2013-2017 (Volume)
Figure Liraglutide Market Forecast and CAGR 2018-2025 (Million USD)
Figure Liraglutide Market Forecast and CAGR 2018-2025 (Volume)
Figure Lixisenatide Market Size and CAGR 2013-2017 (Million USD)
Figure Lixisenatide Market Size and CAGR 2013-2017 (Volume)
Figure Lixisenatide Market Forecast and CAGR 2018-2025 (Million USD)
Figure Lixisenatide Market Forecast and CAGR 2018-2025 (Volume)
Figure Albiglutide Market Size and CAGR 2013-2017 (Million USD)
Figure Albiglutide Market Size and CAGR 2013-2017 (Volume)
Figure Albiglutide Market Forecast and CAGR 2018-2025 (Million USD)
Figure Albiglutide Market Forecast and CAGR 2018-2025 (Volume)
Figure Dulaglutide Market Size and CAGR 2013-2017 (Million USD)
Figure Dulaglutide Market Size and CAGR 2013-2017 (Volume)
Figure Dulaglutide Market Forecast and CAGR 2018-2025 (Million USD)
Figure Dulaglutide Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospital Market Size and CAGR 2013-2017 (Million USD)
Figure Hospital Market Size and CAGR 2013-2017 (Volume)
Figure Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospital Market Forecast and CAGR 2018-2025 (Volume)
Figure Pharmacy Market Size and CAGR 2013-2017 (Million USD)
Figure Pharmacy Market Size and CAGR 2013-2017 (Volume)
Figure Pharmacy Market Forecast and CAGR 2018-2025 (Million USD)
Figure Pharmacy Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2013-2017 (Million USD)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2013-2017 (Volume)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Volume)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2013-2017 (Million USD)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR 2013-2017 (Volume)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Million USD)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure India Market Sales Revenue Share by Company in 2017
Figure India Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure India Market Sales Revenue Share by Type in 2017
Figure India Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure India Market Sales Revenue Share by Application in 2017
Figure India Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Glucagon Like Peptide-1 (GLP-1) Agonists SWOT List
Figure Healthcare & Medical Porter's Five Forces


More Publications